-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - , flushing,
and changes in heart rate and blood
pressure
Oral: 250 to 500 mg per day
Naltrexone Opioid … antagonist; competitively binds to
opioid receptors and blocks the effects of
endogenous opioids such … more or less effective
for adults with specific genotypes (e.g., related to
polymorphisms of the mu-opioid … Seven eligible studies assessed variation in naltrexone
response related to mu-opioid receptor gene … Food and Drug Administration; KQ = Key Question; OPRM1 = mu-opioid receptor gene; QoL = quality of life
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
April 09, 2020 - complications (e.g., for infection, bleeding)*
o Pain, including chronic pain*
o Analgesic (e.g., opioid … complications (e.g., for infection, bleeding)*
o Pain, including chronic pain*
o Analgesic (e.g., opioid … complications (e.g., for infection, bleeding)*
o Pain, including chronic pain*
o Analgesic (e.g., opioid … complications (e.g., for infection, bleeding)*
o Pain, including chronic pain*
o Analgesic (e.g., opioid … complications (e.g., for infection, bleeding)*
o Pain, including chronic pain*
o Analgesic (e.g., opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
May 19, 2020 - Gastrointestinal (constipation, nausea, vomiting)
• Pruritus
• Urinary retention, dry mouth
• Opioid … Gastrointestinal (constipation, nausea,
vomiting)
• Pruritus
• Urinary retention, dry mouth
• Opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
March 23, 2019 - naratriptan, rizatriptan, almotriptan, eletriptan, zolmitriptan, combination
sumatriptan and naproxen)
o Opioid … Central Nervous System Stimulants”[Mesh] OR “Tryptamines”[Mesh]
OR “narcotics”[Mesh] OR “Analgesics, Opioid … Central Nervous System Stimulants”[Mesh] OR “Tryptamines”[Mesh]
OR “narcotics”[Mesh] OR “Analgesics, Opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
August 23, 2012 - Or
“Nitrous oxide induces release of endogenous opioid peptides in the
midbrain, stimulating descending … The data for efficacy of
intravenous opioid labor analgesia would suggest this description for
“opioids … IV
remifentanil is the most popular opioid being used for that purpose
currently, but it can cause … p. 47, I think it would be helpful to note that pethidine is known
as Demerol in the US and is an opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172)
Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13
Opioid: 2 vs. 3
Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
January 01, 2019 - vs non-opioid. … Changes in back pain NRS, leg pain NRS, and RDQ stratified by opioid vs non-opioid treatment at baseline … months, 18 months, 24 months Spinal stenosis severity; employment characteristics; procedure relief; opioid … levels of pain were reported with deteriorating relief below 50%
Data NR NR Most patients received opioid … and non-opioid analgesics, adjuvant analgesics, and some were involved in therapeutic exercise programs
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-2.pdf
May 15, 2023 - 2021]
[Han 2020]
USPSTF-2013
PLCOm2012
N
(Y for
comparator)
Lung cancer screening
eligibility
Opioid … ET
Supporting Algorithmic Equity in a Public Healthcare
System: a Case Study in Opioid Safety
76 … Shah, MBBS, PhD
Supporting Algorithmic Equity in a Public Healthcare System: a Case Study in Opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
April 11, 2018 - Incident opioid drug use and adverse respiratory
outcomes among older adults with COPD. … exp corticosteroid therapy/ or exp Expectorants/ or exp
narcotic analgesic agent/ or exp Analgesics, Opioid … Glucocorticoid* or instruct* or "management plan*" or "Mind-
Body" or Mindfulnes* or narcotic* or Nutrition* or opioid … Glucocorticoid* or
instruct* or "management plan*" or "Mind-Body" or Mindfulnes* or narcotic* or Nutrition* or
opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
April 01, 2020 - These initiatives,
along with the recent publication of
the evidence-based guideline on opioid
use … the Centers for Disease
Control and Prevention in the United States and
the Canadian Guideline for Opioid … Opioid Treatments
for Chronic Pain: A Systematic Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
August 01, 2012 - United States
Epidural • Injection of medications (usually a
combination of local anesthetic and
opioid … A controlled oximetric evaluation
of inhalational, opioid and epidural analgesia in labour.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
January 01, 2022 - Symptoms: 10.7 vs. 8.9 vs. 10.5 years
Pain etiology/type or diagnostic classification: LBP
Current opioid … medication use: 56% vs. 47%
RDQ (0–24)
Pain intensity, Brief Pain Inventory (0–10)
Opioid medication … to - 0.11) vs. 0.15 (95% CI -0.18 to 0.47); between-group difference -0.59 (95% CI -1.05 to -0.13)
Opioid … C
6 months
Opioid Days: 1.61 (0.91) vs. 2.93 (0.93), p=0.31
B vs. … in the 4 weeks prior to baseline: 1% (1/100) vs. 1.2% (1/82)
Use of a moderate opioid in the 4 weeks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - • The Eastern Academic Health Science Network disseminated a toolkit
on its website to support opioid … Opioid deprescribing toolkit. n.d. … https://easternahsn.org/about-us/our-
projects/opioid-deprescribing-toolkit/. … https://easternahsn.org/about-us/our-projects/opioid-deprescribing-toolkit/
https://easternahsn.org/about-us … Opioid deprescribing toolkit. n.d. https://easternahsn.org/about-us/our-
projects/opioid-deprescribing-toolkit
-
effectivehealthcare.ahrq.gov/products/treatments-acute-pain/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
November 01, 2020 - (I) ↑ (+)
Antiemetics
(Dopamine
antagonists),
Antihistamines,
Opioid-like
analgesics
Metoclopramide
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2019.pdf
January 01, 2019 - 2017)
Evidence-Based Guidelines for EMS Administration of Naloxone
(NHTSA)
Management of Suspected Opioid
-
effectivehealthcare.ahrq.gov/products/pain-management-substance-abuse/research
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
January 01, 2023 - acetaldehyde levels37
250 to 500 mg per day
Naltrexone oral Acts as a competitive antagonist at opioid … 50 to 100 mg per day
Naltrexone
intramuscular injectable
Acts as a competitive antagonist at opioid … Naltrexone may also be used to treat a
patient with AUD and a co-occurring opioid use disorder if the … patient wishes to abstain
from opioid use or can do so for a clinically appropriate time before starting … Prevalence of DSM-IV and DSM-5 alcohol,
cocaine, opioid, and cannabis use disorders in a largely substance
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
January 01, 2023 - Opioid use disorder at delivery hospitalization in the United
States: 2012-2016. … Making Healthcare Safer IV: Opioid Stewardship
28. … effectivehealthcare.ahrq.gov/products/mhs4-hcw-training/protocol
https://effectivehealthcare.ahrq.gov/products/mhs4-opioid-stewardship … R18 HS027913-03 Addressing Opioid Use Disorder in Older Adults Through Primary Care Innovation (OUD-
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
March 01, 2014 - wide variety of pharmaceutical agents have been
used to treat the symptom of chronic cough, including
opioid … • Of the agents reviewed, the opioid and certain
nonopioid/nonanesthetic antitussives most frequently … The opioid and
certain nonopioid/nonanesthetic antitussives demonstrated
the most promise for managing … wide variety of pharmaceutical agents have been used
to treat the symptom of chronic cough, including opioid … The opioid and certain nonopioid/
nonanesthetic antitussives most frequently demonstrated
efficacy for